SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001683168-23-008578
Filing Date
2023-11-30
Accepted
2023-11-30 17:20:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS cns_424b3.htm 424B3 102556
  Complete submission text file 0001683168-23-008578.txt   103545
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-275671 | Film No.: 231456665
SIC: 2834 Pharmaceutical Preparations